Kanagawa, Japan

Shinji Matuura



Average Co-Inventor Count = 7.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Kanagawa, JP (2012 - 2014)
  • Tokyo, JP (2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Shinji Matuura

Introduction

Shinji Matuura, an accomplished inventor based in Kanagawa, Japan, has made significant strides in the field of biopharmaceutical research. With a total of four patents to his name, Matuura has focused on developing novel compounds and methodologies that hold great potential for cancer treatment and therapeutic applications.

Latest Patents

Matuura's latest innovations include a method for producing antibody-drug conjugates and the corresponding crystals of those compounds. One of his notable patents describes a method for producing crystal forms of a tricyclic pyrazolopyrimidine derivative. This particular compound is designed to inhibit the effect of HSP90, a crucial protein involved in cancer cell survival. His patent details the hydrochloride of a specific compound that demonstrates antitumor activity, which could pave the way for new anticancer therapies.

Career Highlights

Shinji Matuura is presently associated with Daiichi Sankyo Company, Limited, a leading global pharmaceutical company renowned for its innovative drug development. Throughout his career, Matuura has committed himself to advancing the understanding and treatment of cancer through the implementation of groundbreaking research methodologies.

Collaborations

Matuura collaborates with several esteemed colleagues in his endeavors, notably Hitoshi Ohki and Tooru Okayama. Their combined expertise fosters a dynamic research environment that encourages the development of cutting-edge solutions in the pharmaceutical industry.

Conclusion

In summary, Shinji Matuura's contributions to the field of biotechnology through his innovative patents not only highlight his skills as an inventor but also reflect a broader commitment to improving cancer therapies. His work at Daiichi Sankyo Company continues to influence the medical community and offers hope for enhancing treatment options for patients facing challenging health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…